SPONSORED:

Democrats urge Biden FDA to drop in-person rule for abortion pill

Democrats urge Biden FDA to drop in-person rule for abortion pill
© Getty Images

A group of House Democrats pressed the Food and Drug Administration (FDA) Tuesday to lift “medically unnecessary” restriction on the abortion pill that have been in place for several years.

Under the FDA rule, mifepristone, which is used to end early pregnancies and treat early pregnancy loss, can only be dispensed in person, a requirement that has received renewed criticism during the COVID-19 pandemic.

“Imposing this requirement in the midst of a deadly pandemic—one that has disproportionately impacted communities of color across the United States—needlessly places patients and providers in harm’s way, and further entrenches longstanding health inequities,” Committee Chair Carolyn MaloneyCarolyn MaloneyLawmakers line up behind potential cyber breach notification legislation DeJoy apologizes for mail delays while defending Postal Service changes House panel spars over GameStop frenzy, trading apps MORE (D-N.Y.) and other Democrats on the House Oversight and Reform Committee wrote in a letter to acting FDA Commissioner Janet Woodcock.

ADVERTISEMENT

Democratic Reps. Ayanna PressleyAyanna PressleyPressley says image of Black custodial staff cleaning up Capitol after Jan. 6 riot 'haunts' her DeJoy apologizes for mail delays while defending Postal Service changes DeJoy set for grilling by House Oversight panel MORE (Mass.), Alexandria Ocasio-CortezAlexandria Ocasio-CortezBudget Committee chair pledges to raise minimum wage: 'Hold me to it' Democrats scramble to rescue minimum wage hike Exclusive: How Obama went to bat for Warren MORE (N.Y.), Katie Porter (Calif.), Rashida TlaibRashida Harbi TlaibSix ways to visualize a divided America Jamaal Bowman's mother dies of COVID-19: 'I share her legacy with all of you' Democrats urge Biden FDA to drop in-person rule for abortion pill MORE (Mich.), Cori Bush (Mo.), Debbie Wasserman SchultzDeborah (Debbie) Wasserman SchultzDeSantis threatens to divert vaccines from communities criticizing distribution Lobbying world Democrats urge Biden FDA to drop in-person rule for abortion pill MORE (Fla.), Jackie SpeierKaren (Jackie) Lorraine Jacqueline SpeierHillicon Valley: Google lifting ban on political ads | DHS taking steps on cybersecurity | Controversy over TV 'misinformation rumor mills' House Democrats urge Biden to make his pick for acting FCC chair permanent Lawmakers clash over gun prohibition in Natural Resources Committee room MORE (Calif.), Robin KellyRobin Lynne KellyLawmakers emphasize prioritizing patients' needs in health care policy The Hill's Morning Report - Democrats ready mammoth relief bill for 10-day sprint Overnight Health Care: Biden officials announce funding to track virus variants | Senate Dems unveil public option proposal | White House: Teacher vaccinations not required for schools to reopen MORE (Ill.) and Brenda LawrenceBrenda Lulenar LawrenceCongressional Black Caucus unveils '100 Day Plan' Six ways to visualize a divided America Democrats urge Biden FDA to drop in-person rule for abortion pill MORE (Mich.), as well as Del. Eleanor Holmes NortonEleanor Holmes NortonOVERNIGHT ENERGY: Biden returns to Obama-era greenhouse gas calculation | House passes major public lands package | Biden administration won't defend Trump-era relaxation of bird protections The Hill's 12:30 Report - Presented by Facebook - Divided House on full display Harris visits DC pharmacy to promote vaccine program MORE (D.C.) signed on to the letter.

Health organizations including the American College of Obstetricians and Gynecologists (ACOG) have long argued that the in-person dispensing requirements impede access to abortion and are medically unnecessary because the drug is safe.

In response to the pandemic, the FDA last year suspended in-person dispensing requirements for other drugs but not for mifepristone, prompting a lawsuit from ACOG.

While lower courts sided with ACOG and temporarily ordered the FDA to pause enforcement of the rule while the lawsuit proceeded, the Supreme Court eventually sided with the Trump administration, which argued the requirements were still necessary.

Courts have not yet ruled on the merits of the case, which is being heard by the 4 th Circuit Court of Appeals.

ADVERTISEMENT

But it’s not yet clear how the Department of Justice will respond to the lawsuit now that the Biden administration has taken over.

The FDA could also agree to suspend the in-person requirements, which would make the case moot, according to the American Civil Liberties Union, which is representing ACOG in the lawsuit.

Biden has not yet named a nominee to lead the FDA.

“The Biden-Harris Administration has vowed to follow the science, and the evidence is crystal clear that this in-person pick-up requirement is senseless and dangerous. It’s time to act,” Julia Kaye, staff attorney at the ACLU Reproductive Freedom project and lead counsel on the case, said in a statement.